Buys
Open market- Shares
- Avg price
- Total value
Konstantinos Xynos - Chief Medical Officer at Replimune Group, Inc.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- REPL on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Konstantinos Xynos in Replimune Group, Inc.
Sells
Open market- Shares
- -32,718
- Avg price
- $8.73
- Total value
- -$285,661
Net
Past year- Shares
- -32,718
- Share %
- -100%
- Total value
- -$285,661
Reported holdings for Konstantinos Xynos in Replimune Group, Inc.
Form 4 holding
Chief Medical Officer
Replimune Group, Inc.
- Security class
- Common Stock
- Shares / value
- 224,215
- Estimated value
- $2,908,068
- Report date
- 10 Aug 2026
- Price
- $12.97
- Ownership
- Direct
Form 4 holding
Chief Medical Officer
Replimune Group, Inc.
- Security class
- Employee Stock Option (right to buy)
- Shares / value
- 75,000
- Estimated value
- Report date
- 01 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Konstantinos Xynos in Replimune Group, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.